Is Acasti Pharma Inc (ACST) Stock About to Get Hot Thursday?

Overall market sentiment has been high on Acasti Pharma Inc (ACST) stock lately. ACST receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Acasti Pharma Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ACST!

See Full ACST Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With ACST Stock Today?

Acasti Pharma Inc (ACST) stock has fallen -3.97% while the S&P 500 has gained 0.28% as of 10:55 AM on Thursday, Sep 28. ACST is lower by -$0.11 from the previous closing price of $2.77 on volume of 168,664 shares. Over the past year the S&P 500 has risen 17.52% while ACST is lower by -24.65%. ACST lost -$5.61 per share in the over the last 12 months.

More About Acasti Pharma Inc

Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all which could help to increase treatment compliance and improve patient outcomes. Click Here to get the full Stock Report for Acasti Pharma Inc stock.